“…Since its onset in 2011 (Jonckers et al, 2011), mouse rsfMRI has developed in a number of centres and has grown to become a routine method with a number of applications, reviewed in (Chuang and Nasrallah, 2017;Gozzi and Schwarz, 2016;Hoyer et al, 2014;Jonckers et al, 2015Jonckers et al, , 2013Pan et al, 2015). Prominently, mouse rsfMRI has been used to investigate an extensive list of models, including Alzheimer's disease (Grandjean et al, 2014b, Shah et al, 2013, 2016cWiesmann et al, 2016;Zerbi et al, 2014), motor (DeSimone et al, 2016;Li et al, 2017), affective (Grandjean et al, 2016a), autism spectrum Haberl et al, 2015;Liska et al, 2018;Liska and Gozzi, 2016;Michetti et al, 2017;Sforazzini et al, 2016;Zerbi et al, 2018;Zhan et al, 2014), schizophrenia (Errico et al, 2015;Gass et al, 2016), pain (Buehlmann et al, 2018;Komaki et al, 2016), reward (Charbogne et al, 2017;Mechling et al, 2016), and demyelinating disorders (Hübner et al, 2017). Another application of mouse rsfMRI is the elucidation of large-scale functional alterations exerted by pharmacological agents (Razoux et al, 2013;Shah et al, 2016aShah et al, , 2015.…”